Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS side effect

What is ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS and Recently Reported Side Effects   ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS and 15 most Active Side Effect polls   ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS

CYCLOPHOSPHAMIDE ENBREL  EVISTA  FORTEO  INFLIXIMAB  PROPYLTHIOURACIL TRACLEER  VIBRAMYCIN  


Forteo Side Effects Report #5514596-X
Physician from BELGIUM reported FORTEO problem on Nov 05, 2007. Female patient was diagnosed with osteoporosis, vitamin supplementation, depression and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . FORTEO dosage: unknown. During the same period patient was treated with CALCIUM, OXAZEPAM, TRAZOLAN. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5496416-5
FORTEO problem was reported by a Physician from BELGIUM on Oct 11, 2007. Female patient was diagnosed with osteoporosis, vitamin supplementation, depression and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . FORTEO dosage: unknown. During the same period patient was treated with CALCIUM, SERESTA, TRAZOLAN. Patient was hospitalized. Patient recovered.

Vibramycin Side Effects Report #5379323-8
Consumer or non-health professional from JAPAN reported VIBRAMYCIN problem on June 27, 2007. Female patient, 51 years of age, was diagnosed with acne pustular and was treated with VIBRAMYCIN. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . VIBRAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

Vibramycin Side Effects Report #5379323-8
VIBRAMYCIN problem was reported by a Consumer or non-health professional from JAPAN on June 27, 2007. Female patient, 51 years of age, was diagnosed with acne pustular and was treated with VIBRAMYCIN. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . VIBRAMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.


Tracleer Side Effects Report #5783157-X
Consumer or non-health professional from JAPAN reported TRACLEER problem on June 06, 2008. Male patient, 61 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . TRACLEER dosage: unknown. Patient recovered.

Infliximab Side Effects Report #5702900-9
INFLIXIMAB problem was reported by a Health Professional from UNITED KINGDOM on Apr 01, 2008. Male patient, 31 years of age, was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, glomerulonephritis rapidly progressive, klebsiella infection, . INFLIXIMAB dosage: unknown. During the same period patient was treated with METHOTREXATE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Propylthiouracil Side Effects Report #5371729-6
Consumer or non-health professional from CHINA reported PROPYLTHIOURACIL problem on June 18, 2007. Female patient, 20 years of age, weighting 99.21 lb, was diagnosed with basedow's disease and was treated with PROPYLTHIOURACIL. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, arthralgia, blood albumin decreased, blood thyroid stimulating hormone decreased, exophthalmos, glomerulonephritis, goitre, haematuria, haemoglobin decreased, . PROPYLTHIOURACIL dosage: 300 MG;QD;PO. Patient was hospitalized. Patient recovered.

Tracleer Side Effects Report #5319704-1
TRACLEER problem was reported by a Physician from JAPAN on Apr 19, 2007. Female patient, 66 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, deep vein thrombosis, hot flush, inflammation, purpura, . TRACLEER dosage: 125 MG; 62.5 MG : BID, ORAL. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5300432-3
Physician from FRANCE reported ENBREL problem on Apr 04, 2007. Male patient, 56 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . ENBREL dosage: unknown. Patient recovered.


Evista Side Effects Report #5300908-9
EVISTA problem was reported by a Physician from JAPAN on Apr 06, 2007. Female patient, 72 years of age, was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . EVISTA dosage: 60 MG, QOD. Patient recovered.

Evista Side Effects Report #5310173-4
Physician from JAPAN reported EVISTA problem on Apr 17, 2007. Female patient, 72 years of age, weighting 121.3 lb, was diagnosed with osteoporosis, hypertension, oedema, hyperuricaemia, hyperlipidaemia and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, . EVISTA dosage: 60 MG, QOD. During the same period patient was treated with NORVASC, ALMARL, SPIRONOLACTONE, ALLOPURINOL, KALLIDINOGENASE, D ALFA, PRAVASTAN, BLOPRESS. Patient recovered.

Tracleer Side Effects Report #5278629-0
TRACLEER problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, 66 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: anti-neutrophil cytoplasmic antibody positive vasculitis, deep vein thrombosis, erythema, hot flush, inflammation, oedema peripheral, pain, purpura, white blood cell count increased, . TRACLEER dosage: unknown. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5590362-4
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Jan 08, 2008. Female patient, 65 years of age, was diagnosed with anti-neutrophil cytoplasmic antibody positive vasculitis, temporal arteritis, strongyloidiasis, infection and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, anti-neutrophil cytoplasmic antibody positive vasculitis, haemoptysis, multi-organ failure, strongyloidiasis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, ALBENDAZOLE, BROAD. Patient was hospitalized. Patient recovered.

Propylthiouracil Side Effects Report #5332885-9
PROPYLTHIOURACIL problem was reported by a Physician from SINGAPORE on May 09, 2007. Female patient, 22 years of age, was diagnosed with basedow's disease and was treated with PROPYLTHIOURACIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, anti-neutrophil cytoplasmic antibody positive vasculitis, arthralgia, arthritis, body temperature increased, diarrhoea, episcleritis, goitre, malaise, . PROPYLTHIOURACIL dosage: 100 MG; BID. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS